A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors
Clinical trial NCT01456078 · COMPLETED
Trial details
- NCT number
- NCT01456078
- Sponsor
- Lund University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2018-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.